Win for Added Relacorilant in Platinum-Resistant Ovarian Cancer
(MedPage Today) -- CHICAGO -- Combining investigational relacorilant with nab-paclitaxel (Abraxane) improved progression-free survival (PFS), and demonstrated a clinically meaningful ...